jakez4ut
Patience... It's what's for dinner
- Joined
- Jul 7, 2005
- Messages
- 72,829
- Likes
- 134,212
so you believe that this is inaccurate bc of lack of testing?
If you can find a link for it, that’d be awesome. I’d really like to give that a readIn case ya'll have missed it this morning, there has been trailers rolling across the tv screen on FOX NEWS, OAN, and other national news channels of some potentially game changing news on a possible vaccine out of the Univ. of Pitt that is apparently on a fast track approval to the FDA. In layman terms, the vaccine would be applied in the form of a small patch containing 400 "needles" made from proteins absorbed thru the skin. It has already passed the lab mice test.
If you can find a link for it, that’d be awesome. I’d really like to give that a read
COVID-19 Vaccine Candidate Shows Promise4/2/2020
PITTSBURGH – University of Pittsburgh School of Medicine scientists today announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.
The paper appeared today in EBioMedicine, which is published by The Lancet, and is the first study to be published after critique from fellow scientists at outside institutions that describes a candidate vaccine for COVID-19. The researchers were able to act quickly because they had already laid the groundwork during earlier coronavirus epidemics.
Like others have suggested, there are a lot of variables but a really big one is that there's a huge number of active cases right now. So even if we had no additional cases pop up we'd still need to wait for the active cases to resolve one way or another to know the final mortality rate. jmo.
Most of them wouldn’t need to go to the hospital
“The authors are now in the process of applying for an investigational new drug approval from the U.S. Food and Drug Administration in anticipation of starting a phase I human clinical trial in the next few months.
I guess it does not matter how many people you might spread it to who have no underlying conditions who are going to die from it also. I hope for your sake that any family members lucky enough to take care of you when you become old will have more compassion than you do.Again, death is an inevitable part of life. Disease, famine, and war have been part of the human experience since the beginning. It sucks but to put society on hold over this is insane in my opinion. It’s an infringement of civil liberties and a waste of time considering that all the quarantine does is prolong the spread. Hell I just saw that the CDC director said this could last for two years. No way in hell are we going to be able to continue operating like this for two f***ing years.
At risk people should be allowed to stay home and receive whatever benefits they need, but the rest of us should be allowed to continue on with our lives as we normally would
“The authors are now in the process of applying for an investigational new drug approval from the U.S. Food and Drug Administration in anticipation of starting a phase I human clinical trial in the next few months.
“Testing in patients would typically require at least a year and probably longer,” Falo said. “This particular situation is different from anything we’ve ever seen, so we don’t know how long the clinical development process will take. Recently announced revisions to the normal processes suggest we may be able to advance this faster.”
Not saying it isn’t promising, but it will still be a while before it’s available.
J&J is working to Fast track a vaccine also that is scheduled to start clinical trials in September. Like started above the first human release would be Q1 of 2021, but that is very fast track by FDA standards. J&J just donated $1B dollars to develop a vaccine in hope to deliver a billion doses soon at no profit to the public.“The authors are now in the process of applying for an investigational new drug approval from the U.S. Food and Drug Administration in anticipation of starting a phase I human clinical trial in the next few months.
“Testing in patients would typically require at least a year and probably longer,” Falo said. “This particular situation is different from anything we’ve ever seen, so we don’t know how long the clinical development process will take. Recently announced revisions to the normal processes suggest we may be able to advance this faster.”
Not saying it isn’t promising, but it will still be a while before it’s available.